Prospective Randomized Study on the Effects of Valgus Knee Brace for Knee Osteoarthritis in Chinese Patients

NCT ID: NCT04056845

Last Updated: 2019-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate whether the use of valgus knee brace is useful for patients with medial knee osteoarthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Osteoarthritis of the knee is the commonest type of arthritis affecting both the middle age and geriatric population, which poses a huge burden to our in-patient and out-patient orthopaedic services. Conservative treatment like physiotherapy and analgesic provide temporary symptomatic relief. Surgical treatment like high tibial osteotomy and knee arthroplasty are not without major potential surgical risks and implant-related complications.

Orthotic treatment can theoretically alter the loading to the knee joint and help to reduce the symptoms and disease progression. Small scale biomechanical studies have demonstrated such effects with the use of valgus knee brace (2-4). Though prospective clinical outcome studies on Chinese patients in our locality are lacking.

Valgus knee brace is a non-pharmaceutical, non-invasive option for knee pain. Using a three-point leverage the unloader brace is to shift the stress away from the arthritic area to the normal portion of the knee, maintains good alignment and stability and thus provides significant pain relief during daily activities. It has been commonly used as a first line management option in other countries.

Our aim is to perform a prospective randomized study to look at the difference in outcome measures in osteoarthritic patients with the use of valgus knee brace, on top of the usual regime of conservative treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized prospective study
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
Outcome assessors are blinded from the treatment received

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Knee brace group

Patients in this group will receive a valgus knee brace (Medex K39-OA Corrector), to be worn for at least four hours a day, during the study period, on top of the presrciption of physiotherapy and oral analgesic (diclofenac and panadol).

Group Type EXPERIMENTAL

Valgus knee brace (Medex K39-OA Corrector)

Intervention Type DEVICE

Valgus knee brace given to patients as part of the conservative management for knee osteoarthritis.

Physiotherapy and oral analgesic (diclofenac and panadol)

Intervention Type OTHER

Physiotherapy and oral analgesic (diclofenac and panadol)

Control Group

Patients in this group will receive physiotherapy and oral analgesic (diclofenac and panadol).

Group Type ACTIVE_COMPARATOR

Physiotherapy and oral analgesic (diclofenac and panadol)

Intervention Type OTHER

Physiotherapy and oral analgesic (diclofenac and panadol)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Valgus knee brace (Medex K39-OA Corrector)

Valgus knee brace given to patients as part of the conservative management for knee osteoarthritis.

Intervention Type DEVICE

Physiotherapy and oral analgesic (diclofenac and panadol)

Physiotherapy and oral analgesic (diclofenac and panadol)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 40-80
* History of symptomatic medial unicompartmental knee osteoarthritis \> 6 months
* Willingness to wear the knee brace for a minimum of 4 hours per day during daily activities
* Understanding of the Chinese language
* Ethnic Chinese patients

Exclusion Criteria

* Symptomatic knee osteoarthritis affecting more than one compartment
* Clinical and radiological signs of osteoarthritis over the lateral compartment or patello-femoral joint
* Significant knee effusion or soft tissue compromise preventing long-term knee brace use
* Obesity (BMI\>30)
* Previous surgery on the affected knee other than diagnostic arthroscopy with debridement, soft tissue reconstruction, menisectomy
* Peripheral vascular disease of the lower limb
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Authority, Hong Kong

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Keith Hay-Man Wan

Resident Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Keith Hay-Man Wan, MBChB, FRCSEd(Orth)

Role: PRINCIPAL_INVESTIGATOR

Hospital Authority

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Authority

Hong Kong, , Hong Kong

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Keith Hay-Man Wan, MBChB, FRCSEd(Orth)

Role: CONTACT

+852 90384422

Siu Tong Choi, MBBS, FHKCOS

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Keith Wan, MB ChB, FRCSEd (Orth)

Role: primary

Siu Tong Choi, MBBS

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Fu HC, Lie CW, Ng TP, Chen KW, Tse CY, Wong WH. Prospective study on the effects of orthotic treatment for medial knee osteoarthritis in Chinese patients: clinical outcome and gait analysis. Hong Kong Med J. 2015 Apr;21(2):98-106. doi: 10.12809/hkmj144311. Epub 2015 Mar 10.

Reference Type BACKGROUND
PMID: 25756275 (View on PubMed)

Moyer RF, Birmingham TB, Bryant DM, Giffin JR, Marriott KA, Leitch KM. Valgus bracing for knee osteoarthritis: a meta-analysis of randomized trials. Arthritis Care Res (Hoboken). 2015 Apr;67(4):493-501. doi: 10.1002/acr.22472.

Reference Type BACKGROUND
PMID: 25201520 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HAREC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anatomic Congruent Prosthetic Knee Design
NCT03633201 ACTIVE_NOT_RECRUITING NA